Michael Goldberg is of CareDx, Inc.. Currently has a direct ownership of 139,072 shares of CDNA, which is worth approximately $3.46 Million. The most recent transaction as insider was on Oct 04, 2024, when has been sold 837 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 139K
0.61% 3M change
39.28% 12M change
Total Value Held $3.46 Million

Michael Goldberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 04 2024
BUY
Grant, award, or other acquisition
-
837 Added 0.6%
139,072 Common Stock
Jul 08 2024
BUY
Grant, award, or other acquisition
-
2,963 Added 2.1%
138,235 Common Stock
Jun 14 2024
BUY
Grant, award, or other acquisition
-
10,570 Added 7.25%
135,272 Common Stock
Apr 04 2024
BUY
Grant, award, or other acquisition
-
3,686 Added 2.87%
124,702 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
18,165 Added 13.05%
121,016 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
3,000 Added 2.83%
102,851 Common Stock
Oct 04 2023
BUY
Grant, award, or other acquisition
-
3,052 Added 2.97%
99,851 Common Stock
Jul 06 2023
BUY
Grant, award, or other acquisition
-
2,992 Added 3.0%
96,799 Common Stock
Jun 16 2023
BUY
Grant, award, or other acquisition
-
18,844 Added 16.73%
93,807 Common Stock
Apr 11 2023
BUY
Grant, award, or other acquisition
-
2,391 Added 3.09%
74,963 Common Stock
Jan 06 2023
BUY
Grant, award, or other acquisition
-
2,896 Added 3.84%
72,572 Common Stock
Oct 04 2022
BUY
Grant, award, or other acquisition
-
1,419 Added 2.0%
69,676 Common Stock
Jul 01 2022
BUY
Grant, award, or other acquisition
-
1,127 Added 1.62%
68,257 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
4,863 Added 6.75%
67,130 Common Stock
Apr 11 2022
SELL
Open market or private sale
$18,005 $36.01 p/Share
500 Reduced 0.8%
62,267 Common Stock
Apr 11 2022
BUY
Exercise of conversion of derivative security
$610 $1.22 p/Share
500 Added 0.79%
62,767 Common Stock
Apr 01 2022
BUY
Grant, award, or other acquisition
-
1,000 Added 1.58%
62,267 Common Stock
Mar 09 2022
SELL
Open market or private sale
$16,705 $33.41 p/Share
500 Reduced 0.81%
61,267 Common Stock
Mar 09 2022
BUY
Exercise of conversion of derivative security
$610 $1.22 p/Share
500 Added 0.8%
61,767 Common Stock
Feb 09 2022
SELL
Open market or private sale
$21,480 $42.96 p/Share
500 Reduced 0.81%
61,267 Common Stock
Feb 09 2022
BUY
Exercise of conversion of derivative security
$610 $1.22 p/Share
500 Added 0.8%
61,767 Common Stock
Jan 10 2022
SELL
Open market or private sale
$21,485 $42.97 p/Share
500 Reduced 0.81%
61,267 Common Stock
Jan 10 2022
BUY
Exercise of conversion of derivative security
$610 $1.22 p/Share
500 Added 0.8%
61,767 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
699 Added 1.13%
61,267 Common Stock
Dec 09 2021
SELL
Open market or private sale
$22,705 $45.41 p/Share
500 Reduced 0.82%
60,568 Common Stock

Also insider at

EHTH
eHealth, Inc. Financial Services
MG

Michael Goldberg

South San Francisco, CA

Track Institutional and Insider Activities on CDNA

Follow CareDx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDNA shares.

Notify only if

Insider Trading

Get notified when an Care Dx, Inc. insider buys or sells CDNA shares.

Notify only if

News

Receive news related to CareDx, Inc.

Track Activities on CDNA